Cognitive Behaviour Therapy for Dental Phobia and Anxiety 2013
DOI: 10.1002/9781118499825.ch11
|View full text |Cite
|
Sign up to set email alerts
|

Dental Treatment under Sedation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…Standard therapeutics for fear frequently used by dental providers, such as anxiolytics and more substantial sedation, are offered out of compassion and may permit treatment completion in the short term, but they do nothing to reduce patients' subsequent anxiety or avoidance [7]. Thus, these interventions counterproductively perpetuate the fear → avoidance → dental‐problem → acute‐treatment → fear cycle [8].…”
Section: Introductionmentioning
confidence: 99%
“…Standard therapeutics for fear frequently used by dental providers, such as anxiolytics and more substantial sedation, are offered out of compassion and may permit treatment completion in the short term, but they do nothing to reduce patients' subsequent anxiety or avoidance [7]. Thus, these interventions counterproductively perpetuate the fear → avoidance → dental‐problem → acute‐treatment → fear cycle [8].…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, it is not due to lack of impact, as dental fear has demonstrable impacts on public health. As summarized by the US Surgeon General’s report (US Department of Health and Human Services 2000, p. iii), dental fear leads to “needless pain and suffering, causing devastating complications to an individual’s well-being, with financial and social costs that significantly diminish quality of life and burden American society.” Finally, it is not due to competing evidence-based standard practice, as standard treatment involves receiving intravenous (IV) sedation or anxiolytics (e.g., Milgrom et al 2013), both of which are contraindicated because they do nothing to reduce subsequent anxiety or treatment avoidance (e.g., Wannemueller et al 2011), lead to continued dental health problems (Jöhren et al 2000; Thom et al 2000; Raadal 2013), and perpetuate a pattern of patient fear → avoidance → dental problems. Clearly, the challenge at present is not how to treat dental fear to reduce the financial and human suffering burden to public health but how to disseminate and implement EBIs in a way that recognizes the rewards and barriers in the US health care system.…”
mentioning
confidence: 99%